178 related articles for article (PubMed ID: 20677154)
1. [Detection of complex chromosomal aberrations in patients with multiple myeloma using multiplex fluorescence in situ hybridization].
Jiang YQ; Chen LJ; Zhu Y; Qiu HR; Wang R; Xu JR; Lu H; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):441-4. PubMed ID: 20677154
[TBL] [Abstract][Full Text] [Related]
2. [Multicolor spectral karyotyping (SKY) and its application to the cytogenetic diagnosis of multiple myeloma].
Cigudosa JC; Calasanz MJ; García Miranda JL
Sangre (Barc); 1999 Aug; 44(4):301-4. PubMed ID: 10589283
[No Abstract] [Full Text] [Related]
3. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and application of multiplex FISH in detection of the complex chromosome abnormalities in leukemia].
Zhao M; Chen B; Wang L; Xu L; Cao Q; Su X; Chen S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):375-8. PubMed ID: 12362309
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization.
Drach J; Schuster J; Nowotny H; Angerler J; Rosenthal F; Fiegl M; Rothermundt C; Gsur A; Jäger U; Heinz R
Cancer Res; 1995 Sep; 55(17):3854-9. PubMed ID: 7641204
[TBL] [Abstract][Full Text] [Related]
6. Karyotyping human chromosomes by combinatorial multi-fluor FISH.
Speicher MR; Gwyn Ballard S; Ward DC
Nat Genet; 1996 Apr; 12(4):368-75. PubMed ID: 8630489
[TBL] [Abstract][Full Text] [Related]
7. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping.
Veldman T; Vignon C; Schröck E; Rowley JD; Ried T
Nat Genet; 1997 Apr; 15(4):406-10. PubMed ID: 9090389
[TBL] [Abstract][Full Text] [Related]
8. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
[TBL] [Abstract][Full Text] [Related]
9. Traditional and molecular cytogenetics.
Sawyer JR; Johnson MP; Miller OJ
J Reprod Med; 1992 Jun; 37(6):485-98. PubMed ID: 1619601
[TBL] [Abstract][Full Text] [Related]
10. Spectral karyotyping combined with locus-specific FISH simultaneously defines genes and chromosomes involved in chromosomal translocations.
Tonon G; Roschke A; Stover K; Shou Y; Kuehl WM; Kirsch IR
Genes Chromosomes Cancer; 2000 Apr; 27(4):418-23. PubMed ID: 10719373
[TBL] [Abstract][Full Text] [Related]
11. [Multiple FISH and multiple BAND: Application of cytogenetic and molecular techniques in 5 cases].
Castillo Taucher S; Fuentes AM; Paulos A; Pardo A
Rev Med Chil; 2002 May; 130(5):511-8. PubMed ID: 12143271
[TBL] [Abstract][Full Text] [Related]
12. Use of fluorescence in situ hybridization to clarify a complex chromosomal rearrangement in a child with multiple congenital anomalies.
Spikes AS; Hegmann K; Smith JL; Shaffer LG
Am J Med Genet; 1995 May; 57(1):31-4. PubMed ID: 7645595
[TBL] [Abstract][Full Text] [Related]
13. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.
Mrózek K; Heinonen K; Theil KS; Bloomfield CD
Genes Chromosomes Cancer; 2002 Jun; 34(2):137-53. PubMed ID: 11979548
[TBL] [Abstract][Full Text] [Related]
14. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
[TBL] [Abstract][Full Text] [Related]
15. Combined RxFISH/G-banding allows refined karyotyping of solid tumors.
Micci F; Teixeira MR; Dietrich CU; Saeter G; Bjerkehagen B; Heim S
Hum Genet; 1999 May; 104(5):370-5. PubMed ID: 10394927
[TBL] [Abstract][Full Text] [Related]
16. Application of cross-species color banding (RxFISH) in the study of T-prolymphocytic leukemia.
Espinet B; Solé F; Salido M; Lloveras E; Abella E; Besses C; Serrano S; Woessner S; Florensa L
Haematologica; 2000 Jun; 85(6):607-12. PubMed ID: 10870117
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent in-situ hybridization--some of its applications in clinical cytogenetics.
Gole LA; Bongso A
Singapore Med J; 1997 Nov; 38(11):497-503. PubMed ID: 9550914
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization (FISH) in cytogenetics of leukemia.
Michalová K
Folia Biol (Praha); 1996; 42(6):311-4. PubMed ID: 9158941
[TBL] [Abstract][Full Text] [Related]
19. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal in situ suppression hybridization after Giemsa banding.
Klever M; Grond-Ginsbach C; Scherthan H; Schroeder-Kurth TM
Hum Genet; 1991 Mar; 86(5):484-6. PubMed ID: 2016088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
